Search or choose
Find the right test or package.
Risk stratification in Acute Myeloid Leukemia (AML) by Next Generation Sequencing is a crucial component in the evaluation and management of this hematologic malignancy. NGS is a genetic testing method that allows for the identification of specific chromosomal...
Risk stratification in Acute Myeloid Leukemia (AML) by Next Generation Sequencing is a crucial component in the evaluation and management of this hematologic malignancy. NGS is a genetic testing method that allows for the identification of specific c...
Risk stratification in Acute Myeloid Leukemia (AML) by Next Generation Sequencing is a crucial component in the evaluation and management of this hematologic malignancy. NGS is a genetic testing method that allows for the identification of specific chromosomal abnormalities in leukemia cells.
Risk stratification in Acute Myeloid Leukemia (AML) by Next Generation Sequencing is a crucial component in the evaluation and management of this hematologic malignancy. NGS is a genetic testing method that allows for the identification of specific chromosomal abnormalities in leukemia cells.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.